{
  "note_id": "chen_t2dm_000",
  "scenario": "t2dm",
  "persona": "chen",
  "note_text": "**Patient:** Robert Chen\n**Age:** 42\n**Gender:** M\n**Occupation:** software engineer\n\n**Clinical Note**\n\n**Chief Complaint:**  \nDiabetes follow-up\n\n**History of Present Illness:**  \n42-year-old male with 3-year history of Type 2 Diabetes. Here for routine diabetes management. Last HbA1c 8.2% (3 months ago). On Metformin, but glucose levels still high. Fasting 160-220 mg/dL, postprandial 180-250 mg/dL. Reports GI upset with Metformin, no hypoglycemia. Foot tingling, erectile issues sometimes. Sedentary lifestyle, drinks soda daily.\n\n**Review of Systems:**  \n- **Constitutional:** No weight loss or fever.  \n- **Eyes/Cardiovascular/Respiratory:** No changes noted.  \n- **Gastrointestinal:** GI upset with Metformin.  \n- **Genitourinary:** Erectile dysfunction occasionally.  \n- **Neurological:** Tingling in feet.  \n- **Dermatological:** Skin WNL.\n\n**Physical Examination:**  \n- **Vital Signs:** BP 128/78, HR 78, Temp 98.6\u00b0F, BMI 32.4  \n- **General:** Alert, obese.  \n- **Cardiovascular:** Regular pulse, no murmurs.  \n- **Extremities:** Monofilament test intact. No edema.  \n- **Respiratory:** Grossly intact.  \n- **Feet:** Intact sensation, no deformities.\n\n**Assessment and Plan:**  \n1. **Type 2 Diabetes Mellitus, uncontrolled:**  \n   - Add Semaglutide weekly. Continue Metformin. HbA1c recheck later.  \n   - Refer to diabetes educator.  \n   - Educate on lifestyle changes.\n\n2. **Obesity:**  \n   - Lifestyle advice: Reduce soda, portion control.  \n   - Aim for weight loss.\n\n3. **Essential hypertension, controlled:**  \n   - Continue Lisinopril.\n\n4. **Hyperlipidemia:**  \n   - Continue Atorvastatin.\n\n5. **Complications: Neuropathy symptoms:**  \n   - Monitor, manage glucose.\n\n6. **Preventive Care:**  \n   - Ophthalmology referral.  \n   - Order kidney tests.  \n   - Flu vaccine.\n\n7. **Erectile Dysfunction:**  \n   - Discussed potential treatments.\n\n**Time Spent:** 25 minutes\n\n**Billing Level:** 99214\n\n**Medical Decision Making:**  \nFocused on improving glycemic control with GLP-1 agonist, addressing lifestyle changes critical for cardiovascular risk reduction.",
  "demographics": {
    "age": 42,
    "gender": "M",
    "occupation": "software engineer",
    "name": "Robert Chen"
  },
  "source_gold_note": "gold_t2dm_000",
  "generated_at": "2026-02-14T02:51:34.995934",
  "ground_truth_scores": {
    "completeness": 82,
    "accuracy": 90,
    "compliance": 75,
    "risk": 85,
    "clarity": 80
  }
}